- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insights 674 results
Client Alert
January 26, 2022
Spotlight on PFAS and Other Substances in Cosmetics Likely to Grow in 2022
Client Alert
January 25, 2022
Senators Introduce Bipartisan Bill To End U.S. Dependence On Chinese Rare Earth Elements
Client Alert
January 25, 2022
Infrastructure Bill Paves the Way for New Energy Investments and Technology
Article
January 18, 2022
Looking to the Past for the Future: International Investment Law as a Framework to Protect Private Actors in Outer Space
Client Alert
January 14, 2022
Delaware Chancery Court Issues Highly-Anticipated SPAC-Related Decision
Client Alert
January 13, 2022
Uyghur Forced Labor Prevention Act Signed Into Law
Client Alert
January 6, 2022
Presidential Proclamation To Modify The Harmonized Tariff Schedule Of The United States
Client Alert
January 4, 2022
FDA Alerts Pharmaceutical Manufacturers to Risk of Benzene in Certain Drugs
Client Alert
January 4, 2022
EPA’s Draft Strategic Plan Emphasizes Resilience and Adaption to Climate Change
Client Alert
December 30, 2021
FDA Issues Draft Guidances on Transitioning Devices from EUAs and Agency Enforcement Policies
Client Alert
December 30, 2021
Select Subcommittee on the Coronavirus Crisis Ends 2021 With Several Open Investigations and Promises for Continued Oversight Across Industries
Client Alert
December 20, 2021
Reviving the Holiday Gathering This Year? Avoid Adding Insider Trading Liability to the Mix.